Molecular Imaging of Matrix Metalloproteinase-2 in Atherosclerosis Using a Smart Multifunctional PET/MRI Nanoparticle
Authors:
Open Access
- 1 December 2022
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 17, 6773-6789
Abstract
Background: Matrix metalloproteinases from macrophages are important intraplaque components that play pivotal roles in plaque progression and regression. This study sought to develop a novel multifunctional positron emission tomography (PET) and magnetic resonance imaging (MRI) contrast agents based on MMP-2 cleavable nanoparticles to noninvasive assessment of MMP-2 activity in mouse carotid atherosclerotic plaques. Results: Macrophage-rich vascular lesions were induced by carotid ligation plus high-fat diet and streptozotocin-induced diabetes in CL57/BL6 mice. To render iron oxide nanoparticles (IONP) specific for the extracellular MMP-2, the magnetic nanoparticle base material has been derivatized with 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) for the nuclear tracer 64Cu labeling and the MMP-2-cleavable peptide modified with polyethylene glycol 2000, yielding a multi-modality reporter (64[email protected], MMP2cNPs) for PET/MR imaging. Small animal PET imaging and biodistribution data revealed that MMP2cNPs exhibited remarkable plaque uptake (3.06 ± 0.87% ID/g and 1.83 ± 0.28% ID/g at 4 and 12 h, respectively). And MMP2cNPs were rapidly cleared from the contralateral normal carotid artery, resulting in excellent plaque-to-normal carotid artery contrasts. Furthermore, in vivo MRI showed a preferential accumulation of MMP2cNPs in atherosclerotic lesions compared with the non-cleavable reference compound, MMP2ncNPs. In addition, histological analyses revealed iron accumulations in the carotid atherosclerotic plaque, in colocalization with MMP-2 expression and macrophages. Conclusion: Using a combination of innovative imaging modalities, in this study, we demonstrate the feasibility of applying the novel smart MMP2cNPs as a PET/MR hybrid imaging contrast agent for detection of MMP-2 in atherosclerotic plaque in vivo. Graphical Abstract:Keywords
This publication has 42 references indexed in Scilit:
- Detection and treatment of atherosclerosis using nanoparticlesWIREs Nanomedicine and Nanobiotechnology, 2016
- Experimental study of USPIO-enhanced MRI in the detection of atherosclerotic plaque and the intervention of atorvastatinExperimental and Therapeutic Medicine, 2016
- Magnetic Resonance Imaging of Atherosclerosis Using CD81-Targeted Microparticles of Iron Oxide in MiceBioMed Research International, 2015
- 64 Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2015
- A hybrid approach for scalable sub-tree anonymization over big data using MapReduce on cloudJournal of Computer and System Sciences, 2014
- Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic PlaquesCirculation Research, 2013
- Development of a Magnetic Resonance Imaging Protocol for the Characterization of Atherosclerotic Plaque by Using Vascular Cell Adhesion Molecule-1 and Apoptosis-Targeted Ultrasmall Superparamagnetic Iron Oxide DerivativesArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- In Vivo Bioluminescence Imaging of Inducible Nitric Oxide Synthase Gene Expression in Vascular InflammationMolecular Imaging and Biology, 2010
- Matrix metalloproteinase-2 predicts mortality in patients with acute coronary syndromeClinical Science, 2009
- Nanoparticle PET-CT Imaging of Macrophages in Inflammatory AtherosclerosisCirculation, 2008